dr. paik on resistance mutations in nsclc
Published 6 years ago • 215 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:21
dr. paik discusses advances in squamous cell lung cancer
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
1:14
dr. brahmer on targeting driver mutations in nsclc
-
1:37
dr. awad on acquired resistance to met inhibitors in nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
1:28
dr. paik on the potential approval of lorlatinib for patients with alk-positive nsclc
-
5:46
resistance mechanisms in egfr nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
5:58
common mutations in lung cancer
-
1:21
dr. kris on the fda approval of dacomitinib in egfr nsclc
-
2:23
dr. zhu on primary resistance to osimertinib in egfr-mutant nsclc
-
10:26
monoclonal antibodies in squamous cell lung cancer
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:11
dr. belani discusses driver mutations in nsclc
-
6:30
testing for kras mutations in nsclc
-
2:20
dr. liu on resistance mechanisms in egfr-mutant lung cancer
-
6:12
resistance in egfr-mutant lung cancer
-
4:28
overcoming resistance to egfr inhibitors in nsclc